178
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
POSTERS
> SBRT for locally advanced pancreatic cancer (LAPC): a retrospective
multi-institutional experience
G. Macchia (Italy), A. Arcelli, A.G. Morganti, F. Bertini, A. Guido,
L. Fuccio, F. Dalla Torre, S. Cilla, V. Scotti, M.E. Rosetto, I. Djan,
S. Parisi, G.C. Mattiucci, V. Valentini, M. Fiore, P. Bonomo, A. Bacigalupo,
R.M. Niespolo, P. Gabriele, F. Deodato
PO-0680
> SBRT VS standard chemoradiation in locally advanced pancreatic
cancer (LAPC): a case-control study
A. Arcelli (Italy), F. Bertini, A.G. Morganti, A. Guido, L. Fuccio,
F. Deodato, S. Cilla, F. Dalla Torre, V. Scotti, E.M. Rosetto, I. Djan,
S. Parisi, G.C. Mattiucci, V. Valentini, M. Fiore, P. Bonomo, A. Bacigalupo,
R.M. Niespolo, P. Gabriele, G. Macchia
PO-0681
> Re-irradiation for oligo-recurrence from esophageal cancer with
radiotherapy history
K. Jingu (Japan), Y. Niibe, H. Yamashita, K. Katsui, T. Matsumoto,
T. Nishina, A. Terahara
PO-0682
> Impact of the radiation dose on hepatic perfusion evaluated using
mebrofenin liver scintigraphy
B. De Bari (France), T. Breuneval, M. Zeverino, S. Godin, L. Deantonio,
J. Prior, J. Bourhis, R. Moeckli, M. Ozsahin
PO-0683
> Opposite pharmacokinetics of sorafenib modulates by liver irradiation
– concurrent versus sequential
C.H. Hsieh (Taiwan), L.Y. Wang, T.H. Tsai, Y.J. Chen
PO-0684
> The value of postoperative adjuvant therapy for pT2-3 esophageal
cancer treated by radical resection
S. Zhu (China), L. Shuguang, L. Youmei, S. Wenbin, L. Juan,
L. Zhukun, S. Jingwei, L. Teng
PO-0685
> Perfusion imaging of colorectal liver metastases treated with
bevacizumab and SBRT
H. Chung (Canada), J. Detsky, P. Munoz-Schuffenegger, L. Milot,
W. Chu, C. MacDonald, Y. Ko
PO-0686
> Spleen dosimetry are associated with lymphopenia during radiotherapy
for hepatocellular carcinoma
Q. Zhao, R. Wang, T. Liu, J. Yue (China)
PO-0687